By Devika Patel
Knoxville, Tenn., April 13 - Intraop Medical Corp. completed a $1.1 million tranche of a $1.5 million private placement of 10% senior secured debentures on Thursday, according to an 8-K filed Monday with the Securities and Exchange Commission.
The debentures mature June 30, 2009. Of the securities, $725,000 were sold to Lacuna Venture Fund LLLP, $250,000 were sold to company director Rawleigh Ralls and $125,000 were sold to E.U. Capital Venture, Inc.
Investors also received warrants for 27,678,567 common shares, which are exercisable at $0.028 for five years.
Proceeds will be used for working capital and other general corporate purposes.
Sunnyvale, Calif.-based Intraop specializes in the development, manufacturing, marketing and servicing of the Mobetron, a mobile electron beam system designed for intraoperative radiotherapy treatment of cancer, coronary vascular restenosis and other medical applications.
Issuer: | Intraop Medical Corp.
|
Issue: | Senior secured debentures
|
Amount: | $1.5 million
|
Maturity: | June 30, 2009
|
Coupon: | 10%
|
Price: | Par
|
Yield: | 10%
|
Warrants: | For 27,678,567 shares
|
Warrant expiration: | Five years
|
Warrant strike price: | $0.028
|
Investors: | Lacuna Venture Fund LLLP (for $725,000), Rawleigh Ralls (for $250,000), E.U. Capital Venture, Inc. (for $125,000)
|
Settlement date: | April 9 (for $1.1 million)
|
Stock symbol: | OTCBB: IOPM
|
Stock price: | $0.03 at close April 9
|
Market capitalization: | $11 million
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.